T2Bmeet
Q3 T2Bmeet @ SF 2026
Register for T2Bmeet @ San Francisco
T2B Pro or T2B Student members: get your promo code here
Look for an automated confirmation email and calendar invite within one business day from our event management platform, Luma. If you do not receive it, check your spam folder or contact us at [email protected].
How Exelixis Grew Employee Volunteering 41% and Made the Business Case for Giving
Employee giving and volunteering can support several priorities at once: employee engagement, internal communications, social storytelling, and a company’s relationship and reputation with its local community and beyond. At Exelixis, these priorities come together in a Public Affairs-led program that grew employee volunteering 41% from 2024 to 2025.
In this case study, Kathleen Brennan and Lindsay Treadway will share how Exelixis creates a steady pipeline of engagement opportunities, uses a strategic year-round communications plan and channels to sustain participation, and partners across many internal departments to drive engagement among the Company’s employees. They will also discuss how external organizations and technology help a lean team expand its capacity, manage giving and volunteer activities, and capture meaningful data.
Attendees will gain a practical look at the operating model, communications approach, and measures of success that have helped Exelixis grow participation while strengthening employee sentiment, corporate storytelling, and its presence in the local community.
Key Takeaways:
- Structure a giving and volunteer program that can grow with clear ownership and limited staff.
- Sustain participation through a consistent communications cadence, accessible opportunities and employee recognition.
- Partner across HR, Employee Experience and external organizations to expand reach and execution capacity.
- Use technology to simplify giving, matching, volunteer tracking and reporting.
- Connect program metrics to employee engagement, communications value and community impact.
Program:
-
4:30-5:30 p.m. – Check-in and networking
-
5:30-6 p.m. – How Exelixis Grew Employee Volunteering 41% and Made the Business Case for Giving
-
6-7 p.m. – Reception and networking
About our host
Exelixis
Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by drug discovery and development excellence, we are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules and biotherapeutics. This comprehensive approach harnesses decades of robust investment in our science and partnerships to advance our pipeline of franchise molecules, including our novel oral kinase inhibitor zanzalintinib, and to extend the impact of our flagship commercial product, CABOMETYX® (cabozantinib). Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more patients hope for the future. For information about the company and its mission to help cancer patients recover stronger and live longer, visit www.exelixis.com, follow @ExelixisInc on X (Twitter), like Exelixis, Inc. on Facebook and follow Exelixis on LinkedIn.